These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36528478)

  • 41. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
    Murtola TJ; Peltomaa AI; Talala K; Määttänen L; Taari K; Tammela TLJ; Auvinen A
    Eur Urol Focus; 2017 Apr; 3(2-3):212-220. PubMed ID: 28753762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
    Sabol RA; Ledet EM; Jaeger E; Hatton W; Moses M; Lankford A; Zaheria A; Barata P; Layton JL; Lewis BE; Sartor O
    Prostate; 2021 May; 81(7):427-432. PubMed ID: 33760238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age at diagnosis and age at death in familial prostate cancer.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Germline copy number variation analysis in Finnish families with hereditary prostate cancer.
    Laitinen VH; Akinrinade O; Rantapero T; Tammela TL; Wahlfors T; Schleutker J
    Prostate; 2016 Feb; 76(3):316-24. PubMed ID: 26552734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.
    Goh CL; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Thomas K; Selvadurai ED; Woode-Amissah R; Dadaev T; Mahmud N; Castro E; Olmos D; Guy M; Govindasami K; O'Brien LT; Hall AL; Wilkinson RA; Sawyer EJ; Al Olama AA; Easton DF; Kote-Jarai Z; Parker CC; Eeles RA
    BJU Int; 2013 Sep; 112(5):666-73. PubMed ID: 23320731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives.
    Zheng G; Sundquist J; Sundquist K; Ji J
    Cancer Med; 2022 May; 11(10):2117-2124. PubMed ID: 35312170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate Cancer Incidence and Mortality in Relationship to Family History of Prostate Cancer; Findings From The PLCO Trial.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2019 Aug; 17(4):e837-e844. PubMed ID: 31213414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.
    Karlsson Q; Brook MN; Dadaev T; Wakerell S; Saunders EJ; Muir K; Neal DE; Giles GG; MacInnis RJ; Thibodeau SN; McDonnell SK; Cannon-Albright L; Teixeira MR; Paulo P; Cardoso M; Huff C; Li D; Yao Y; Scheet P; Permuth JB; Stanford JL; Dai JY; Ostrander EA; Cussenot O; Cancel-Tassin G; Hoegel J; Herkommer K; Schleutker J; Tammela TLJ; Rathinakannan V; Sipeky C; Wiklund F; Grönberg H; Aly M; Isaacs WB; Dickinson JL; FitzGerald LM; Chua MLK; Nguyen-Dumont T; ; Schaid DJ; Southey MC; Eeles RA; Kote-Jarai Z
    Eur Urol Oncol; 2021 Aug; 4(4):570-579. PubMed ID: 33436325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups.
    McHugh J; Saunders EJ; Dadaev T; McGrowder E; Bancroft E; Kote-Jarai Z; Eeles R
    Br J Cancer; 2022 Jun; 126(10):1366-1373. PubMed ID: 34923574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of childhood mortality in family members of men with poor semen quality.
    Hanson HA; Mayer EN; Anderson RE; Aston KI; Carrell DT; Berger J; Lowrance WT; Smith KR; Hotaling JM
    Hum Reprod; 2017 Jan; 32(1):239-247. PubMed ID: 27927843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer.
    Bancroft EK; Castro E; Bancroft GA; Ardern-Jones A; Moynihan C; Page E; Taylor N; Eeles RA; Rowley E; Cox K
    Psychooncology; 2015 Nov; 24(11):1492-9. PubMed ID: 25872100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rare germline genetic variants and risk of aggressive prostate cancer.
    Nguyen-Dumont T; MacInnis RJ; Steen JA; Theys D; Tsimiklis H; Hammet F; Mahmoodi M; Pope BJ; Park DJ; Mahmood K; Severi G; Bolton D; Milne RL; Giles GG; Southey MC
    Int J Cancer; 2020 Oct; 147(8):2142-2149. PubMed ID: 32338768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative Risks for Lethal Prostate Cancer Based on Complete Family History of Prostate Cancer Death.
    Albright FS; Stephenson RA; Agarwal N; Cannon-Albright LA
    Prostate; 2017 Jan; 77(1):41-48. PubMed ID: 27527734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.
    Fossati N; Karnes RJ; Boorjian SA; Moschini M; Morlacco A; Bossi A; Seisen T; Cozzarini C; Fiorino C; Noris Chiorda B; Gandaglia G; Dell'Oglio P; Joniau S; Tosco L; Shariat S; Goldner G; Hinkelbein W; Bartkowiak D; Haustermans K; Tombal B; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2017 Jun; 71(6):886-893. PubMed ID: 27484843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death.
    Nurminen R; Lehtonen R; Auvinen A; Tammela TL; Wahlfors T; Schleutker J
    Eur J Cancer; 2013 Oct; 49(15):3335-43. PubMed ID: 23830236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial.
    Godtman RA; Holmberg E; Khatami A; Stranne J; Hugosson J
    Eur Urol; 2013 Jan; 63(1):101-7. PubMed ID: 22980443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
    Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
    Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.
    Roobol MJ; Kranse R; Bangma CH; van Leenders AG; Blijenberg BG; van Schaik RH; Kirkels WJ; Otto SJ; van der Kwast TH; de Koning HJ; Schröder FH;
    Eur Urol; 2013 Oct; 64(4):530-9. PubMed ID: 23759326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.